Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment

Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HAND in EcoHIV-infected mice

(2019) Boe-Hyun Kim et al.   AIDS

The importance of buprenorphine research in the opioid crisis

(2019) Sarah A. Pendergrass et al.   MOLECULAR PSYCHIATRY

Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes

(2018) Matias Jaureguiberry-Bravo et al.   JOURNAL OF LEUKOCYTE BIOLOGY

EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment

(2018) Chao-Jiang Gu et al.   PLoS Pathogens

N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders

(2017) Michael T. Nedelcovych et al.   JOURNAL OF MEDICINAL CHEMISTRY

Mechanisms of CNS Viral Seeding by HIV + CD14 + CD16 + Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders

(2017) Mike Veenstra et al.   mBio

Neurological Complications of HIV Infection

(2017) Shelli Farhadian et al.   Current Infectious Disease Reports

Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis

(2016) Matias Jaureguiberry-Bravo et al.   CURRENT HIV RESEARCH

HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

(2016) Deanna Saylor et al.   Nature Reviews Neurology

Buprenorphine Decreases the CCL2-Mediated Chemotactic Response of Monocytes

(2015) Loreto Carvallo et al.   JOURNAL OF IMMUNOLOGY

Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders

(2014) Dionna Williams et al.   CURRENT HIV RESEARCH

Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users

(2014) Donald B. Smith et al.   JOURNAL OF NEUROVIROLOGY

Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice

(2013) J. William Barwatt et al.   DRUG AND ALCOHOL DEPENDENCE

Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection

(2012) Anupa Kamat et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Inflammatory monocytes and the pathogenesis of viral encephalitis

(2012) Rachael L Terry et al.   Journal of Neuroinflammation

Role of the mu-opioid receptor in opioid modulation of immune function

(2011) Jana Ninković et al.   AMINO ACIDS

Mice Chronically Infected with Chimeric HIV Resist Peripheral and Brain Superinfection: A Model of Protective Immunity to HIV

(2011) Jennifer L. Kelschenbach et al.   Journal of Neuroimmune Pharmacology

Editorial NeuroAIDS review

(2010) Paul Shapshak et al.   AIDS

Chemokine Receptor Ccr2 Is Critical for Monocyte Accumulation and Survival in West Nile Virus Encephalitis

(2010) J. K. Lim et al.   JOURNAL OF IMMUNOLOGY

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology

(2009) Richard M. Ransohoff   IMMUNITY

Ligand stabilization of CXCR4/δ-opioid receptor heterodimers reveals a mechanism for immune response regulation

(2008) Oscar M. Pello et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: Lessons from human and nonhuman primate studies

(2008) Tracy Fischer-Smith et al.   JOURNAL OF NEUROVIROLOGY